Sex Transm Dis 2010,37(12):745–750 PubMedCrossRef Competing inter

Sex Transm Dis 2010,37(12):745–750.PubMedCrossRef Competing interests QX was previously employed by Osel, Mountain View, CA, the company that has provided the bioengineered Transferase inhibitor strains for this study. Authors’ contributions HSY wrote the manuscript, ran the immunoassays and conducted the experiments along with RNF. RNF was responsible for the direction of the study, experimental design and data integrity. QX provided all bacterial strains and bioengineered derivatives,

directed the western blot and gp120 binding assays, reviewed the progress and manuscript, and provided comments. All authors read and approved the final manuscript.”
“Background Mycobacterium abscessus mycobacteria are increasingly being cultured selleck chemicals from respiratory tract specimens collected from patients NU7441 molecular weight with chronic pulmonary

diseases, including cystic fibrosis [1–9]. These mycobacteria are also responsible for skin and soft-tissue infections following surgical and cosmetic practices [10–12] and catheter-related bacteremia [13, 14]. These infections are particularly critical for immune-compromised patients and may be fatal [15]. Water is suspected as a source of infection, as M. abscessus mycobacteria have been isolated from tap water [16]. Moreover, M. abscessus mycobacteria have been shown to be resistant to water-borne free-living amoebae [17, 18]. M. abscessus infections are also associated with treatment

failure owing, due to the natural broad-spectrum resistance to antibiotics in addition to acquired resistance, with subtle differences in the antibiotic susceptibility pattern being observed among isolates [19]. Indeed, M. abscessus is comprised of a heterogeneous group of mycobacteria currently classified into M. abscessus subsp. abscessus and M. abscessus subsp. bolletii[20, 21], with the later subspecies accommodating mycobacteria previously identified as “Mycobacterium bolletii” or “Mycobacterium Etoposide mouse massiliense” [18, 22]. However, these organisms are nearly indistinguishable using phenotypic tests including the mycolic acid pattern analysis and share 100% 16S rRNA gene sequence similarity [20]. They were initially differentiated on the basis of >3% rpoB gene sequence divergence and different antimicrobial susceptibility patterns [23, 24]. Nevertheless, confusing results based on rpoB sequencing have been reported [21], and combining sequencing of the rpoB, hsp65 and secA genes has been advocated for the optimal identification of the M. abscessus mycobacteria [25]. To further decrypt the diversity and genetic relationships among M. abscessus organisms, we investigated a collection of reference, sequenced genomes and clinical M.

Comments are closed.